Anebulo Pharmaceuticals, Inc. (ANEB) Ownership
ANEB ownership summary
as of October 21, 2026- Institutions
- 0.0% of shares outstanding
- Insiders
- 40.84% of shares outstanding
- Shares outstanding
- 40.8M
- Float
- 24.1M shares available to trade
- Short interest
- 2.11% 146K shares short
- Days to cover
- 1.65 short interest up 188.7% vs prior month
- Insiders 40.84%
- Other investors 59.16%
ANEB top institutional holders
15 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | 22NW, LP | 0.00% | — | — | −15.5M (−100.0%) | March 31, 2026 |
| 2 | State Street Corp | 0.00% | — | — | −12,768 (−100.0%) | March 31, 2026 |
| 3 | Ikarian Capital, LLC | 0.00% | — | — | −17,736 (−100.0%) | March 31, 2026 |
| 4 | BlackRock Inc | 0.00% | — | — | −23,790 (−100.0%) | March 31, 2026 |
| 5 | Tower Research Capital LLC | 0.00% | — | — | −3,230 (−100.0%) | March 31, 2026 |
| 6 | Northern Trust Corp | 0.00% | — | — | −21,994 (−100.0%) | March 31, 2026 |
| 7 | Citadel Advisors Llc | 0.00% | — | — | −24,239 (−100.0%) | March 31, 2026 |
| 8 | Mangrove Partners | 0.00% | — | — | −2.5M (−100.0%) | March 31, 2026 |
| 9 | UBS Group AG | 0.00% | — | — | −2,334 (−100.0%) | March 31, 2026 |
| 10 | Renaissance Technologies Corp | 0.00% | — | — | −25,098 (−100.0%) | March 31, 2026 |
| 11 | Morgan Stanley - Brokerage Accounts | 0.00% | — | — | −399,404 (−100.0%) | March 31, 2026 |
| 12 | Geode Capital Management, LLC | 0.00% | — | — | −160,760 (−100.0%) | March 31, 2026 |
| 13 | JPMorgan Chase & Co | 0.00% | — | — | −2,253 (−100.0%) | March 31, 2026 |
| 14 | Nantahala Capital Management, LLC | 0.00% | — | — | −3.0M (−100.0%) | March 31, 2026 |
| 15 | Bank of America Corp | 0.00% | — | — | −382 (−100.0%) | March 31, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 15, 0 holders added 0 shares and 15 cut 21.7M.
ANEB top mutual fund and ETF holders
1 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | SSgA U.S. Total Market Index Strategy | <0.01% | 82 | $24 | −2 (−2.4%) | September 30, 2025 |
Funds report holdings monthly or quarterly; dates differ by fund.
ANEB insider transactions
latest 1| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2024-12-23 | Aron R English | Buy | $0.99 | 10,101,010 | $10.0M |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
ANEB shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns ANEB
Institutional investors own 0.0% of Anebulo Pharmaceuticals's shares and insiders 40.84%. The largest holder is 22NW, LP with 0.00% of the shares (0), as of March 31, 2026. Among the top 15 institutions, 0 added shares and 15 reduced their stake in the latest filings. Short interest is 2.11% of the float, or 1.65 days of average trading volume. The share count rose 76.6% since 2020.
Related: ANEB analyst forecast, ANEB key metrics. See the ANEB stock overview for the latest quote and news.
ANEB ownership FAQ
Who owns the most Anebulo Pharmaceuticals stock?
The largest shareholders of Anebulo Pharmaceuticals are 22NW, LP (0.00%), State Street Corp (0.00%), Ikarian Capital, LLC (0.00%), BlackRock Inc (0.00%), Tower Research Capital LLC (0.00%).
What percentage of Anebulo Pharmaceuticals is owned by institutions?
Institutions hold 0.0% of Anebulo Pharmaceuticals's shares outstanding; insiders hold 40.84%.
Which funds own Anebulo Pharmaceuticals?
The largest fund holders of Anebulo Pharmaceuticals are SSgA U.S. Total Market Index Strategy (<0.01%).
What is Anebulo Pharmaceuticals's short interest?
146K shares of Anebulo Pharmaceuticals were sold short, 2.11% of the float; at the average daily volume it would take 1.65 days to cover.
Are insiders buying or selling Anebulo Pharmaceuticals?
Of the latest 1 reported insider transactions in Anebulo Pharmaceuticals (since December 23, 2024), 1 were purchases and 0 were sales.
How many shares of Anebulo Pharmaceuticals are outstanding?
Anebulo Pharmaceuticals has 40.8M shares outstanding, of which 24.1M are in the public float.